Search

Search Results

• ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY

  Priyanka Sehrawat, Ashutosh Biswas, Prabhat Kumar, Paras Singla, Naveet Wig, Lalit Dar, Rita Sood

  e2018023

  2018-04-20

  https://doi.org/10.4084/mjhid.2018.023

  3191

  PDF: 1163

  HTML: 401

• SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology

  Firas Kreidieh, Sally Temraz

  e2020078

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.078

  1088

  PDF: 967

  HTML: 337

• TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

  Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo

  e2025039

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.039

  2282

  PDF: 1629

  HTML: 274

• MECHANISM OF SARS-COV-2 INVASION INTO THE LIVER AND HEPATIC INJURY IN PATIENTS WITH COVID-19

  XiaoTian Zhang, Yanhui Yu, Chao Zhang, Lijuan Zhao, Hongrui Wang, Guoqing Wang, Ming Yang

  e2022003

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.003

  1936

  PDF: 1105

  HTML: 311

• EBV IN HODGKIN LYMPHOMA

  Giuseppina Massini, Doerte Siemer, Stefan Hohaus

  e2009013

  https://doi.org/10.4084/mjhid.2009.013

  1671

  PDF: 604

  HTML: 13958

• THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis

  Nicola Semeraro, Prof. Mario Colucci

  e2021045

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.045

  2000

  PDF: 820

  HTML: 225

• DETECTION OF ANTINUCLEAR ANTIBODIES TARGETING INTRACELLULAR SIGNAL TRANSDUCTION, METABOLISM, APOPTOTIC PROCESSES AND CELL DEATH IN CRITICAL COVID-19 PATIENTS

  HADI YASSINE

  e2022076

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.076

  1373

  PDF: 1015

  HTML: 343

  Suppl. Figure: 184

  Suppl. Tables: 207

• ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19

  Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam

  e2022036

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.036

  882

  PDF: 525

  HTML: 393

• COMPARISON OF THE CLINICAL AND LABORATORY FEATURES OF COVID AND INFLUENZA IN CHILDREN

  Davide Pata, Danilo Buonsenso, Piero Valentini

  e2022065

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.065

  1154

  PDF: 807

  HTML: 233

• Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases

  Mariam Markouli, Panagiotis Diamantopoulos, Asimenia Halioti, Stavroula Lontou, Marina Mantzourani

  e2026006

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.006

  841

  PDF: 627

  Suppl. Files: 124

  HTML: 96

• CLINICAL SIGNS AND TREATMENT OF NEW-ONSET BONE MARROW FAILURE ASSOCIATED SARS-COV-2 INFECTION IN CHILDREN : A SINGLE INSTITUTION PROSPECTIVE COHORT STUD

  Mervat A M youssef, Ebtisam Shawky hmed, Dalia Tarik Kamal, khalid Elsayh,, Mai A Abdelfatta, Hyam Hassan Mahran Mahran, Mostafa M Embaby

  e2024034

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.034

  1221

  PDF: 1307

  HTML: 123

• SEPSIS-ASSOCIATED DISSEMINATED INTRAVASCULAR COAGULATION AND THROMBOEMBOLIC DISEASE

  Nicola Semeraro, Concetta T. Ammollo, Fabrizio Semeraro, Mario Colucci

  e2010024

  2010-08-06

  https://doi.org/10.4084/mjhid.2010.024

  3376

  PDF: 1785

  HTML: 4556

• Pidotimod in paucisymptomatic SARS-CoV2 infected patients Pidotimod in COVID-19

  Claudio Ucciferri, Barone Mirko, Jacopo Vecchiet, Katia Falasca

  e2020048

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.048

  3062

  PDF: 1884

  HTML: 981

• Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure

  SUPARNO CHAKRABARTI

  e2020047

  2020-06-28

  https://doi.org/10.4084/mjhid.2020.047

  1201

  PDF: 925

  HTML: 290

• PATHOPHISIOLOGY OF SICKLE CELL DISEASE AND NEW DRUGS FOR THE TREATMENT

  Lucia De Franceschi

  e2009024

  2009-12-26

  1069

  PDF: 654

  HTML: 11083

• COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

  Federico Mercolini, Simone Cesaro

  e2022009

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.009

  2522

  PDF: 944

  HTML: 306

• The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients

  Hesham Elsabah, Mahmood B. Aldabt, Ruba Taha, Dina Sameh Soliman, Halima Elomri, Feryal Ibrahim

  e2020082

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.082

  1002

  PDF: 366

  HTML: 207

• PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID

  Francesco Rodeghiero

  e2021032

  2021-04-29

  https://doi.org/10.4084/MJHID.2021.032

  2616

  PDF: 943

  HTML: 549

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  1794

  PDF: 1686

  HTML: 890

• ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY   Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.

  Ming Tong, Xiquan Yan, Yu Jiang, Zhaoxia Jin, Shengjiao Zhu, Lianhong Zou, Yanjuan Liu, Qing Zheng, Guoqiang Chen, Ruifeng Gui Gui, Zhilan Zhou, Xiaotong Han, Jiangming He, Siqing Yin, Changchun Ma, Wen Xiao, Yong Zeng, Fang Chen, Yimin Zhu

  e2022033

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.033

  1308

  PDF: 733

  HTML: 330

• Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era

  Serena Vita, Emanuela Giacobini, Patrizia De Marco, Martina Rueca, Cesare Ernesto Maria Gruber, Alessia Beccacece, Laura Scorzolini, Valentina Mazzotta, Carmen Pinnetti, Priscilla Caputi, Daniele Focosi, Enrico Girardi, Andrea Antinori, Fabrizio Maggi, Alessandra D'Abramo, Emanuele Nicastri, Spallanzani COVID-19 case Investigation Team

  e2024043

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.043

  1310

  PDF: 946

  HTML: 91

• Bacteraemia Among Patients with Sickle Cell Disease in Nigeria: Association with Spleen Size and Function

  adama isah ladu, Mairo Usman Kadaura, Mohammed Dauda, Abubakar Sadiq Baba, Caroline Jeffery, Abubakar Farate, Adekunle Adekile, Imelda Bates, Russell Dacombe

  e2023054

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.054

  803

  PDF: 521

  HTML: 131

• ELEVATED P-SELECTIN IN SEVERE COVID-19: CONSIDERATIONS FOR THERAPEUTIC OPTIONS P-Selectine and COVID-19

  Chiara Agrati, Veronica Bordoni, alessandra sacchi, germana grassi, nicola petrosillo, emanuele nicastri, franca del nonno, giampiero d'offizi, fabrizio palmieri, luisa marchioni, maria rosaria capobianchi, andrea antinori, giuseppe ippolito, Michele Bibas

  e2021016

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.016

  1895

  PDF: 706

  HTML: 238

• EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES

  Pietro Tralongo, Arianna Bakacs, Luigi Maria Larocca

  e2024042

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.042

  4149

  PDF: 1720

  HTML: 1033

• PRELIMINARY STUDY OF SCD14 AND SCD163 AS PREDICTORS OF DISEASE SEVERITY AND ICU ADMISSION IN COVID-19: RELATION TO HEMATOLOGICAL PARAMETERS, BLOOD MORPHOLOGICAL CHANGES AND INFLAMMATORY BIOMARKERS

  hend Attia

  e2023046

  2023-08-29

  https://doi.org/10.4084/MJHID.2023.046

  1053

  PDF: 564

  HTML: 176

• Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

  Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

  e2022043

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.043

  1364

  PDF: 589

  HTML: 223

• NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa

  Alessandro Matte, Filippo Mazzi, Enrica Federti, Oliviero Olivieri, Lucia De Franceschi

  e2019002

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.002

  6892

  PDF: 3663

  HTML: 773